Detalhe da pesquisa
1.
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence.
Cell
; 179(1): 236-250.e18, 2019 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31495571
2.
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.
Cancer Immunol Immunother
; 70(6): 1541-1555, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33201337
3.
TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma.
Cancer Immunol Immunother
; 68(9): 1493-1500, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501955
4.
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.
Cancer Cell
; 42(4): 623-645.e10, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38490212
5.
MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2.
Cancer Immunol Res
; 11(7): 909-924, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074069
6.
Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells.
Cancer Immunol Res
; 10(9): 1127-1140, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731225
7.
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy.
J Clin Oncol
; 40(4): 369-381, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34860572
8.
Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment Resistance.
Clin Cancer Res
; 27(7): 2074-2086, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446566
9.
Reprogramming lymphocytes for the treatment of melanoma: From biology to therapy.
Adv Drug Deliv Rev
; 141: 104-124, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31276707